MariposAI

Company Overview

Snapshot

Founded in November 2025 by Noam Shomron and Oria Altman, MariposAI operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.

Business overview

MariposAI is a Health Tech & Life Sciences company focused on digital medical diagnostics within the healthcare sector. The company develops a continuous learning AI system designed to identify breast cancer risks significantly earlier than traditional clinical diagnosis. Utilizing a proprietary algorithm, MariposAI's technology analyzes decades of longitudinal health data to detect subtle physiological patterns, aiming to shift oncology from reactive treatment to proactive monitoring. The system integrates with existing healthcare databases to provide scalable, data-driven insights for clinical decision support.

Company Intelligence Q&A

What is MariposAI's primary focus?

MariposAI is focused on developing a continuous learning AI system for early breast cancer signal detection, aiming to identify risks well in advance of traditional clinical diagnosis.

When was MariposAI founded?

MariposAI was founded in November 2025.

Who are the founders of MariposAI?

MariposAI was founded by Noam Shomron and Oria Altman.

What technology does MariposAI utilize?

MariposAI utilizes a proprietary algorithm to analyze decades of longitudinal health data, identifying subtle physiological patterns that precede symptomatic stages of breast cancer.

What is the strategic goal of MariposAI's technology?

The strategic goal of MariposAI's technology is to improve patient outcomes by enabling significantly earlier intervention in oncology, shifting from reactive treatment to proactive monitoring.